Total Payments
$5,363
2024 Payments
$751.98
Companies
40
Transactions
253
Medicare Patients
2,392
Medicare Billing
$318,040
Payment Breakdown by Category
Food & Beverage$5,286 (98.6%)
Other$34.93 (0.7%)
Education$29.05 (0.5%)
Consulting$13.10 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,286 | 248 | 98.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $34.93 | 2 | 0.7% |
| Education | $29.05 | 2 | 0.5% |
| Consulting Fee | $13.10 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,813 | 73 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $774.96 | 50 | $0 (2023) |
| Gilead Sciences, Inc. | $530.93 | 21 | $0 (2024) |
| Celgene Corporation | $375.41 | 16 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $240.44 | 13 | $0 (2023) |
| Phathom Pharmaceuticals, Inc. | $155.95 | 3 | $0 (2024) |
| Takeda Pharmaceuticals America, Inc. | $140.82 | 12 | $0 (2017) |
| Madrigal Pharmaceuticals | $125.48 | 1 | $0 (2024) |
| Janssen Biotech, Inc. | $120.27 | 6 | $0 (2023) |
| Avanir Pharmaceuticals, Inc. | $106.28 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $751.98 | 24 | ABBVIE INC. ($270.51) |
| 2023 | $962.92 | 34 | AbbVie Inc. ($387.07) |
| 2022 | $845.02 | 27 | ABBVIE INC. ($405.94) |
| 2021 | $617.81 | 32 | AbbVie Inc. ($278.34) |
| 2020 | $553.23 | 25 | AbbVie Inc. ($212.57) |
| 2019 | $637.42 | 42 | Gilead Sciences, Inc. ($133.33) |
| 2018 | $557.69 | 37 | Takeda Pharmaceuticals U.S.A., Inc. ($257.42) |
| 2017 | $436.56 | 32 | Takeda Pharmaceuticals America, Inc. ($140.82) |
All Payment Transactions
253 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $24.35 | General |
| Category: GI | ||||||
| 10/23/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $5.15 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $125.48 | General |
| Category: LIVER DISEASE | ||||||
| 10/16/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/03/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: NEUROSCIENCE | ||||||
| 09/23/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $22.37 | General |
| Category: Neuroscience | ||||||
| 09/18/2024 | Boston Scientific Corporation | Autotome RX 49 (Device) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: Autotome_ENDO | ||||||
| 08/05/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: VIROLOGY | ||||||
| 07/29/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $10.27 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/03/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/10/2024 | VIVUS LLC | PANCREAZE (Drug) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/03/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: VIROLOGY | ||||||
| 05/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.93 | General |
| 04/30/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/29/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ, HUMIRA | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: IMMUNOLOGY | ||||||
| 04/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.92 | General |
| 04/12/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $33.74 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/08/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.37 | General |
| Category: Neuroscience | ||||||
| 03/25/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $32.53 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/26/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $4.81 | General |
| Category: VIROLOGY | ||||||
| 02/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $100.80 | General |
| Category: IMMUNOLOGY | ||||||
| 02/08/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/07/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.85 | General |
| 01/22/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: VIROLOGY | ||||||
| 12/19/2023 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $6.43 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 528 | 562 | $404,478 | $71,307 |
| 2022 | 11 | 557 | 605 | $394,958 | $72,231 |
| 2021 | 12 | 660 | 748 | $439,044 | $89,950 |
| 2020 | 12 | 647 | 732 | $377,916 | $84,552 |
Total Patients
2,392
Total Services
2,647
Medicare Billing
$318,040
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 133 | 133 | $118,503 | $17,881 | 15.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 57 | 58 | $61,306 | $12,835 | 20.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 144 | 153 | $89,658 | $12,331 | 13.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 74 | 96 | $28,512 | $9,494 | 33.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 47 | 47 | $53,717 | $8,562 | 15.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 29 | 29 | $33,833 | $5,563 | 16.4% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | Facility | 2023 | 12 | 12 | $8,196 | $1,805 | 22.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $6,915 | $1,420 | 20.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 19 | $3,838 | $1,417 | 36.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 113 | 150 | $44,550 | $13,910 | 31.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 135 | 140 | $82,040 | $11,631 | 14.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 93 | 96 | $85,536 | $11,286 | 13.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 53 | 54 | $56,551 | $11,117 | 19.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 32 | 32 | $38,464 | $6,290 | 16.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 47 | 47 | $21,667 | $5,927 | 27.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 22 | 22 | $26,444 | $4,315 | 16.3% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 27 | 28 | $13,972 | $2,388 | 17.1% |
| 43255 | Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 12 | 13 | $11,479 | $2,210 | 19.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 12 | $6,840 | $1,786 | 26.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 11 | 11 | $7,415 | $1,371 | 18.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 160 | 246 | $73,062 | $24,789 | 33.9% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 103 | 103 | $91,773 | $13,238 | 14.4% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 155 | 157 | $92,002 | $12,780 | 13.9% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 45 | 45 | $47,565 | $9,676 | 20.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 69 | 69 | $31,809 | $8,806 | 27.7% |
About Dr. Maria Valdes, MD
Dr. Maria Valdes, MD is a Gastroenterology healthcare provider based in Naples, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1902890809.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maria Valdes, MD has received a total of $5,363 in payments from pharmaceutical and medical device companies, with $751.98 received in 2024. These payments were reported across 253 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($5,286).
As a Medicare-enrolled provider, Valdes has provided services to 2,392 Medicare beneficiaries, totaling 2,647 services with total Medicare billing of $318,040. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Naples, FL
- Active Since 09/07/2005
- Last Updated 09/23/2020
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1902890809
Products in Payments
- MAVYRET (Drug) $402.04
- ZEPOSIA (Drug) $391.76
- RINVOQ (Biological) $367.11
- Epclusa (Drug) $336.38
- ENTYVIO (Biological) $302.29
- Entyvio (Biological) $241.38
- CREON (Drug) $230.96
- XIFAXAN (Drug) $190.51
- HUMIRA (Biological) $175.93
- VOQUEZNA (Drug) $155.95
- SKYRIZI (Biological) $142.84
- Humira (Biological) $132.50
- REZDIFFRA (Drug) $125.48
- Amitiza (Drug) $118.95
- VIBERZI (Drug) $111.97
- Linzess (Drug) $94.93
- GATTEX (Drug) $89.71
- NUEDEXTA (Drug) $87.55
- Aimovig (Biological) $85.55
- Trintellix (Drug) $82.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Naples
Kevin Dolehide, D.o, D.O
Gastroenterology — Payments: $44,791
Gastroenterology $44,791
Michael Cohen, M.d, M.D
Gastroenterology — Payments: $25,545
Gastroenterology $25,545
Jan Barrios, Md, MD
Gastroenterology — Payments: $12,386
Gastroenterology $12,386
Dr. Steven Meckstroth, M.d, M.D
Gastroenterology — Payments: $9,989
Gastroenterology $9,989
Dr. Manuel Bustamante, M.d, M.D
Gastroenterology — Payments: $9,767
Gastroenterology $9,767
Dr. Alexandra Grace, Do, Mph, DO, MPH
Gastroenterology — Payments: $9,425
Gastroenterology $9,425